CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Merck Serono against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Aug 21, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Unitary Combination Of Fsh And HcgFERRINGMay 5, 2020
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGDec 22, 2017

Explore Merck Serono's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 16, 2024Cladribine Regimen For Treating Multiple Sclerosis1
Jan 17, 2018Cladribine Regimen For Treating Multiple Sclerosis1
Dec 13, 2017The Puro-Dhfr Quadrifunctional Marker And Its Use In Protein Production1

Top competitors of Merck Serono

Top competitors of Merck Serono based on patent oppositions.